Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient.

about

Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient.

Item

http://www.wikidata.org/entity/Q36729327

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Same sibling marrow following ...... ukemia in a pediatric patient.

@ast

Same sibling marrow following ...... ukemia in a pediatric patient.

@en

type

Item

label

Same sibling marrow following ...... ukemia in a pediatric patient.

@ast

Same sibling marrow following ...... ukemia in a pediatric patient.

@en

prefLabel

Same sibling marrow following ...... ukemia in a pediatric patient.

@ast

Same sibling marrow following ...... ukemia in a pediatric patient.

@en

P1476

Same sibling marrow following ...... ukemia in a pediatric patient.

@en

P2093

Andrew Pham

http://www.w3.org/2001/XMLSchema#string

LaMarr Taylor Smith

http://www.w3.org/2001/XMLSchema#string

Pamela Kempert

http://www.w3.org/2001/XMLSchema#string

Roy L Kao

http://www.w3.org/2001/XMLSchema#string

Theodore B Moore

http://www.w3.org/2001/XMLSchema#string

P2860

Which donor or graft source should you choose for the strongest GVL? Is there really any difference

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation

Umbilical cord blood transplantation--how, when and for whom?

Graft-versus-host disease induced graft-versus-leukemia effect: greater impact on relapse and disease-free survival after reduced intensity conditioning

Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia in the ATRA and ATO era

Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129

Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.

Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia.

Induction mortality, ATRA administration, and resource utilization in a nationally representative cohort of children with acute promyelocytic leukemia in the United States from 1999 to 2009.

P304

337-341

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PETR.12677

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Satiro N De Oliveira

P577

2016-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26849401

http://www.w3.org/2001/XMLSchema#string

P921

sibling

P932

4807975

http://www.w3.org/2001/XMLSchema#string